GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound of formula A [US20220024908A1] | TGRX-326 | TGRX326
Compound class:
Synthetic organic
Comment: The chemical structure for deulorlatinib was obtained from WHO proposed INN list 131 (August 2024). Chemically it is a deuterated analogue of the approved dual ALK/ROS1 inhibitor lorlatinib. Deulorlatinib is claimed in Shenzen Targetrx patent US20220024908A1 [1], and we predict that deulorlatinib is the INN for their lead compound TGRX-326 (based on their disclosed pipeline and a meeting abstract [2]).
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13094 | deulorlatinib |
Synonyms ![]() |
| compound of formula A [US20220024908A1] | TGRX-326 | TGRX326 |
Database Links ![]() |
|
| CAS Registry No. | 2131126-33-3 (source: WHO INN record) |
| GtoPdb PubChem SID | 500839898 |
| PubChem CID | 162703963 |
| Search Google for chemical match using the InChIKey | IIXWYSCJSQVBQM-LMUHODJSSA-N |
| Search Google for chemicals with the same backbone | IIXWYSCJSQVBQM |
| Search PubMed clinical trials | deulorlatinib |
| Search PubMed titles | deulorlatinib |
| Search PubMed titles/abstracts | deulorlatinib |
| UniChem Compound Search for chemical match using the InChIKey | IIXWYSCJSQVBQM-LMUHODJSSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | IIXWYSCJSQVBQM-LMUHODJSSA-N |